683 Capital Management »

D-market shares owned by 683 Capital Management

Quarter-by-quarter ownership of D-market (HEPS) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in D-market

Tip: Access up to 7 years of quarterly data

All positions including D-market held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in D-market by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 500k 2.91

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
NVIDIA Corporation Put Option (NVDA)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Capital One Financial (COF)
Abbvie Put Option (ABBV)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Anaptysbio Inc Common (ANAB)
Alnylam Pharmaceuticals (ALNY)
Uniqure Nv SHS (QURE)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Becton, Dickinson and (BDX)
Molina Healthcare (MOH)

View all positions for 683 Capital Management

Top funds holding D-market

VR Advisory Services
State Street Corporation
Bnp Paribas Arbitrage, Snc
UBS Group
Morgan Stanley
683 Capital Management
Citadel Advisors
Rangeley Capital
Nomura Asset Management International
GAM Holding
Russell Investments
Standard Life Aberdeen
Schonfeld Strategic Advisors
Geode Capital Management
GSA Capital Partners

View all funds holding D-market